Source comparison
DSIP vs MK-677 Which Better Comparison: Full Compound Analysis
Primary Mechanism Delta opioid receptor agonist modulating sleep-wake transitions and delta-wave sleep Ghrelin receptor agonist (GHSR-1a) stimulating pulsatile GH secretion DSIP targets sleep architecture; MK-677 targets anabolic signaling. Non-overlapping pat
This comparison does not assign a generated winner or score.
- Primary Mechanism
- Delta opioid receptor agonist modulating sleep-wake transitions and delta-wave sleep
- Ghrelin receptor agonist (GHSR-1a) stimulating pulsatile GH secretion
- DSIP targets sleep architecture; MK-677 targets anabolic signaling. Non-overlapping pathways
- Half-Life
- 30–40 minutes (requires precise timing relative to sleep onset)
- ~24 hours (sustained effect with once-daily dosing)
- DSIP is transient and timing-dependent; MK-677 provides stable 24-hour coverage
- Administration Route
- Subcutaneous or intramuscular injection only (no oral bioavailability)
- Orally bioavailable (no injection required)
- MK-677's oral route is a major practical advantage for long-term study protocols
- Typical Research Dose
- 50–100mcg administered 20–30 minutes before sleep
- 10–50mg once daily (25mg is standard in clinical trials)
- Dosing frequency and timing requirements differ significantly
- Primary Research Application
- Sleep architecture studies, circadian rhythm modulation, stress-related sleep disruption
- Growth hormone axis research, anabolic signaling, IGF-1 pathway studies
- Choose based on whether outcome measure is sleep physiology or GH-mediated effects
- Side Effect Profile
- Minimal. Mild drowsiness if timing is off; no appetite or metabolic effects
- Increased appetite (30–50%), mild fluid retention (10–20%), transient glucose elevation
- DSIP is cleaner for metabolic studies; MK-677 requires dietary control and glucose monitoring
- Stacking Compatibility
- Compatible with GH secretagogues (e.g., MK-677, CJC-1295) for synergistic recovery
- Compatible with sleep modulators (e.g., DSIP) or other anabolic peptides
- Stacking DSIP + MK-677 targets both sleep and GH axes without receptor competition
- Cost per Research Cycle
- Lower unit cost but requires daily injections (higher cumulative cost over weeks)
- Higher unit cost but once-daily oral dosing (lower cumulative cost over weeks)
- MK-677's convenience offsets higher per-dose cost in long-term protocols
- Best Fit For
- Researchers investigating sleep quality, delta-wave sleep, or circadian disruption models
- Researchers investigating GH secretion, anabolic signaling, or body composition
- Non-competing tools. Selection depends entirely on research objective